| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Company | Research | Scientific journal | Date | Type of cooperation | University | Country | Scientist 1 | Scientist 2 | Scientist 3 | Scientist 4 | Scientist 5 | ||||||||||
2 | Philip Morris/Vectura Fertin Pharma | Blood and urine multi-omics analysis of the impact of e-vaping, smoking, and cessation: from exposome to molecular responsess | Scientific reports (Nature) | 21/2/2014 | Research cooperation | University of Rochester Medical Center | USA | Laurel Baglia | Rachel Berg | Timothy Curran | ||||||||||||
3 | Philip Morris/Vectura Fertin Pharma | Nicotine-mediated effects in neuronal and mouse models of synucleinopathy | Frontiers Neuroscience | 31/8/2023 | Research cooperation | University of California | USA | Cassia Overk | Eliezer Masliah | |||||||||||||
4 | Philip Morris/Vectura Fertin Pharma | Inactivation of SARS-CoV-2 on salt-coated surfaces: an in vitro study | Archives of microbiology | 30/6/2023 | Research cooperation | University of Berne | Switzerland | Monika Gsell Albert | ||||||||||||||
5 | Philip Morris/Vectura Fertin Pharma | Acclimation strategies of the green alga Chlorella vulgaris to different light regimes revealed by physiological and comparative proteomic analyses | Journal of experimental botany | 17/8/2023 | Research cooperation | University of Liège | Belgium | Claire Remacle | ||||||||||||||
6 | Vectura | Δ9-Tetrahydrocannabinol (THC): A Critical Overview of Recent Clinical Trials and Suggested Guidelines for Future Research | Journal of clinical medicine | 07/03/2024 | Research cooperation | The University of Maine, University of South Florida | USA | Peter Pressman | Wallace Hayes | |||||||||||||
7 | Vectura/Otitopic | Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response | Journal of thrombosis and thrombolysis | Jan 2024 | Conflict of interest | Sinai Hospital of Baltimore | USA | Paul Gurbel | ||||||||||||||
8 | Vectura/Otitopic | Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory | Journal of thrombosis and thrombolysis | Apr. 2024 | Conflict of interest | Sinai Hospital of Baltimore | USA | Paul Gurbel | ||||||||||||||
9 | Vectura | A systematic review and network meta-analysis of pharmaceutical interventions used to manage chronic pain | Scientific reports (Nature) | 18/1/2024 | Conflict of interest | Imperial College | UK | Arun Bhaskar | ||||||||||||||
10 | Vectura | Safety and efficacy of continuous subcutaneous levodopa-carbidopa infusion (ND0612) for Parkinson's disease with motor fluctuations (BouNDless): a phase 3, randomised, double-blind, double-dummy, multicentre trial | The Lancet Neurology | May 2024 | Conflict of interest | University Hospital of Toulouse | France | Olivier Rascol | ||||||||||||||
11 | Vectura | The safety/tolerability of opicapone when used early in Parkinson's disease patients with levodopa-induced motor fluctuations: A post-hoc analysis of BIPARK-I and II | Frontiers in neurology | 23/8/2022 | Conflict of interest | University Hospital of Toulouse | France | Olivier Rascol | ||||||||||||||
12 | Vectura | Opicapone versus placebo in the treatment of Parkinson's disease patients with end-of-dose motor fluctuation-associated pain: rationale and design of the randomised, double-blind OCEAN (OpiCapone Effect on motor fluctuations and pAiN) trial | BMC Neurology | 12/3/2022 | Conflict of interest | University Hospital of Toulouse | France | Olivier Rascol | ||||||||||||||
13 | Vectura | Operator-patient sex discordance and periprocedural outcomes of percutaneous coronary intervention (from the ORPKI Polish National Registry) | Advances in interventional cardiology | Jun 2023 | Conflict of interest | Mount Sinai School of Medicine | USA | Roxana Mehran | ||||||||||||||
14 | Vectura | Reply: The ROTA-CUT randomised trial: push the button harder | EuroIntervention | 19/2/2014 | Conflict of interest | Mount Sinai School of Medicine | USA | Roxana Mehran | ||||||||||||||
15 | Vectura | Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial | EuroIntervention | 01/01/2024 | Conflict of interest | Mount Sinai School of Medicine | USA | Roxana Mehran | ||||||||||||||
16 | Vectura | Safety and Efficacy of Ticagrelor Monotherapy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: An Individual Patient Data Meta-Analysis of TWILIGHT and TICO Randomized Trials | Circulation | 20/2/2024 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
17 | Vectura | Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium | Circulation | 20/6/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
18 | Vectura | Short-Term DAPT and DAPT De-Escalation Strategies for Patients With Acute Coronary Syndromes: A Systematic Review and Network Meta-Analysis | Circulation. Cardiovascular interventions | Apr. 2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
19 | Vectura | Bleeding and Ischemic Risks of Ticagrelor Monotherapy After Coronary Interventions | Journal of the American College of Cardiology | 22/8/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
20 | Vectura | Comparison of Intravascular Imaging, Functional, or Angiographically Guided Coronary Intervention | Journal of the American College of Cardiology | 5/12/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
21 | Vectura | The Heart-Brain Connection in Myocardial Infarction in Women: A Dilemma to Tackle | Journal of the American College of Cardiology | 24/10/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
22 | Vectura | Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial | American Journal of Cardiology | 1/12/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
23 | Vectura | US County-Level Variation in Preterm Birth Rates, 2007-2019 | JAMA Open network | 1/12/2023 | Conflict of interest | University of Oklahoma | USA | Roxana Mehran | ||||||||||||||
24 | Vectura | Implications of Social Disadvantage Score in Cardiovascular Outcomes and Risk Assessment: Findings From the Multi-Ethnic Study of Atherosclerosis | Circulation. Cardiovascular quality and outcomes | 7/1/2023 | Conflict of interest | Johns Hopkins Bloomberg School of Public Health | USA | Michael Joseph Blaha | ||||||||||||||
25 | Vectura | Incidental Coronary Artery Calcium on Chest CT in Persons Without Known Atherosclerotic Cardiovascular Disease | JAMA Internal medicine | 1/10/2023 | Conflict of interest | Johns Hopkins Bloomberg School of Public Health | USA | Michael Joseph Blaha | ||||||||||||||
26 | Vectura | Type 2 Diabetes Mellitus: Now in the Cardiologist's Wheelhouse | Journal of the American College of Cardiology | 17/10/2023 | Conflict of interest | Johns Hopkins Bloomberg School of Public Health | USA | Michael Joseph Blaha | ||||||||||||||
27 | Vectura | Lipoprotein(a), Residual Cardiovascular Risk, and the Search for Targeted Therapy | Journal of the American College of Cardiology | 23/4/2024 | Conflict of interest | Johns Hopkins Bloomberg School of Public Health | USA | Michael Joseph Blaha | ||||||||||||||
28 | Vectura | Ticagrelor with or without aspirin following percutaneous coronary intervention in high-risk patients with concomitant peripheral artery disease: A subgroup analysis of the TWILIGHT randomized clinical trial | American Heart Journal | 6/3/2024 | Conflict of interest | University of Oklahoma | USA | Dominick J. Angiolillo | ||||||||||||||
29 | Vectura | North American perspective on the 2023 European Society of Cardiology guidelines for the management of acute coronary syndromes | European Heart Journal. Acute cardiovascular care | 9/02/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
30 | Vectura | The Evolving Field of Acute Coronary Syndrome Management: A Critical Appraisal of the 2023 European Society of Cardiology Guidelines for the Management of Acute Coronary Syndrome | Journal of clinical medicine | 25/03/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
31 | Vectura | Extended Clopidogrel Monotherapy vs DAPT in Patients With Acute Coronary Syndromes at High Ischemic and Bleeding Risk: The OPT-BIRISK Randomized Clinical Trial | JAMA Cardiology | 17/4/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
32 | Vectura | Prehospital crushed versus integral prasugrel loading dose in STEMI patients with a large myocardial area | EuroIntervention | 1/4/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
33 | Vectura | Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography | Cardiovascular revascularization medicine | Mar. 2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
34 | Vectura | The Lipid-Platelet Interplay: Unraveling the Effects of PCSK9 Inhibition on Platelet Reactivity | Thrombosis and haemostasis | 19/3/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
35 | Vectura | Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study | Thrombosis and haemostasis | Mar. 2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
36 | Vectura | One-month DAPT with ticagrelor and aspirin for patients undergoing coronary artery bypass grafting: rationale and design of the randomised, multicentre, double-blind, placebo-controlled ODIN trial | EuroIntervention | 04/03/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
37 | Vectura | Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis | JAMA Cardiology | 20/3/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
38 | Vectura | Antithrombotic therapy in patients with acute coronary syndrome: similarities and differences between a European expert consensus document and the 2023 European Society of Cardiology guidelines | European Heart Journal. Acute cardiovascular care | September 2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
39 | Vectura | Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention | Circulation, cardiovascular interventions | April 2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
40 | Vectura | Optimizing LDL-cholesterol management in ACS patients: Breaking inertia and implementing intensified therapies | International Journal of Cardiology | 1/4/2024 | Conflict of interest | University of Florida | USA | Dominick J. Angiolillo | ||||||||||||||
41 | Vectura | When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review | Journal of the American College of Cardiology | 23/1/2024 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | Roxana Mehran | |||||||||||||
42 | Vectura | Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event: Insights From the VICTORIA Trial | JAMA Cardiology | 1/6/2021 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
43 | Vectura | P2Y12 Inhibitor Monotherapy Combined With Colchicine Following PCI in ACS Patients: The MACT Pilot Study | JACC Cardiovascular interventions | 14/8/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
44 | Vectura | Clinical Pharmacokinetics and Pharmacodynamics of CSL112 | Clinical Pharmacokinetics | Apr. 2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
45 | Vectura | The evaluation and management of coagulopathies in the intensive therapy units | European Heart Journal. Acute cardiovascular care | 2/6/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
46 | Vectura | Long-Term Clopidogrel Monotherapy After Percutaneous Coronary Intervention: Will the Pupil Surpass the Master? | Journal of the American College of Cardiology | 17/10/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
47 | Vectura | Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study | JACC Cardiovascular interventions | 23/10/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
48 | Vectura | European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey | International Journal of Cardiology | 1/9/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
49 | Vectura | DAPT guided by platelet function tests or genotyping after PCI: pros and cons | EuroIntervention | 18/9/2023 | Conflict of interest | University of Florida, Mount Sinai School of Medicine | USA | Dominick J. Angiolillo | ||||||||||||||
50 | Vectura/Fertin Pharma | Migraine Prevalence, Environmental Risk, and Comorbidities in Men and Women Veterans | JAMA Network open | 4/3/2024 | Conflict of interest | University of California | USA | Nathaniel M Schuster | ||||||||||||||
51 | Vectura/Fertin Pharma | Debunking myths in headache diagnosis for the pain practitioner | Regional Anesthesia & Pain Medicine | 10/10/2023 | Conflict of interest | University of California | USA | Nathaniel M Schuster | ||||||||||||||
52 | Vectura | Side effects following vaccination in multiple sclerosis: a prospective, multi-centre cohort study | Scientific reports (Nature) | 02/2023 | Conflict of interest | University of Rostock | Germany | Micha Löbermann | ||||||||||||||
53 | Vectura | Automatic analysis of bronchus-artery dimensions to diagnose and monitor airways disease in cystic fibrosis | Thorax | 21/09/2023 | Conflict of interest | Erasmus MC Sophia Children's Hospital | NL | Harm Tiddens | ||||||||||||||
54 | Vectura | Bridging Treatment Implementation Gaps in Patients With Heart Failure: JACC Focus Seminar 2/3 | Journal of the American College of Cardiology | 8/8/2023 | Conflict of interest | Baim Institute for Clinical Research | USA | C. Michael Gibson | ||||||||||||||
55 | Vectura | Real-life effects of benralizumab on airway oscillometry in severe eosinophilic asthma | BMJ Open respiratory research | May 2023 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
56 | Vectura | Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy | The Lancet. Respiratory magazine | Jan 2022 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
57 | Vectura | Repeatability of impulse oscillometry in patients with severe asthma | The European respiratory journal | 31/12/2021 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
58 | Vectura | Combined medical and surgical therapy for chronic rhinosinusitis with nasal polyposis | The Lancet. Respiratory magazine | Apr 2022 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
59 | Vectura | Oscillometry bronchodilator response in adult moderate to severe eosinophilic asthma patients: A prospective cohort study | Clinical and experimental allergy | Sep 2022 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
60 | Vectura | Forced Vital Capacity and Low Frequency Reactance Area Measurements Are Associated with Asthma Control and Exacerbations | Lung | Jun 2022 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
61 | Vectura | Combining biomarkers for prognostic modelling of Parkinson's disease | Journal of Neurology, Neurosurgery, and Psychiatry | 16/5/2022 | Conflict of interest | University of Glasgow | UK | Donald Grosset | ||||||||||||||
62 | Vectura | Genetics of validated Parkinson's disease subtypes in the Oxford Discovery and Tracking Parkinson's cohorts | Journal of Neurology, Neurosurgery, and Psychiatry | 22/6/2022 | Conflict of interest | University of Glasgow | UK | Donald Grosset | ||||||||||||||
63 | Vectura | Echocardiographic pressure-strain loop-derived stroke work of the right ventricle: validation against the gold standard | ESC Heart Failure | Oct 2023 | Conflict of interest | Imperial College London | UK | Hossein Ardeschir Ghofrani | ||||||||||||||
64 | Vectura | Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study | The Lancet. Respiratory magazine | Jan. 2022 | Conflict of interest | University of Kansas | USA | Mario Castro | ||||||||||||||
65 | Vectura | Impact of Biologic Therapy on the Small Airways Asthma Phenotype | Lung | Dec. 2022 | Conflict of interest | University of Dundee School of Medicine | UK | Brian Lipworth | ||||||||||||||
66 | Vectura | Gender gap in deep brain stimulation for Parkinson's disease | NPJ Parkinson's disease | 20/4/2022 | Conflict of interest | University of Padua | Italy | Angelo Antonini | ||||||||||||||
67 | Vectura | Uncertainty analysis of chest X-ray lung height measurements and size matching for lung transplantation | Journal of thoracic disease | Apr. 2022 | Conflict of interest | USA | Ramsey Hachem | |||||||||||||||
68 | Vectura Fertin Pharma | Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series | Med (New York) | 8/9/2023 | Conflict of interest | University of Sydney | Australia | Jonathan Iredell | ||||||||||||||
69 | Fertin Pharma | Medicated chewing gums with nicotine | Journal of Pharmaceutical and Biomedical Analysis | 5/2/2022 | Research cooperation | University of Southern Denmark | Denmark | Jessie Poulsen | Annette Bauer-Brandl | |||||||||||||
70 | Syqe | The pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronic pain: A randomized, double-blinded, placebo-controlled trial | European Journal of Pain | 12/06/2020 | Conflict of interest and research cooperation | Tel Aviv University, RamBam academic hospital, Technion | Israel | Shlomo Almog | Simon Vulfsons | Elon Eisenberg | Miri Ogintz | |||||||||||
71 | Syqe | Vaporized D-limonene selectively mitigates the acute anxiogenic effects of Δ9-tetrahydrocannabinol in healthy adults who intermittently use cannabis | Drug and alcohol dependence | 1/4/2024 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
72 | Syqe | Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples | Frontiers in pharmacology | 18/3/2024 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
73 | Syqe | Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review | JAMA Psychiatry | 01/01/2023 | Research cooperation | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
74 | Syqe | Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial | JAMA Network open | 1/2/2023 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
75 | Syqe | Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain | Neuropsychopharmacology | Oct. 2023 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
76 | Syqe | Likelihood of Positive Urine Screens of THC-COOH After Daily Use of Full-Spectrum Hemp Extracts Varies as a Function of Screening Criterion Used | Therapeutic Drug Monitoring | 1/2/2023 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
77 | Syqe | A cross-sectional survey on cannabis: Characterizing motives, opinions, and subjective experiences associated with the use of various oral cannabis products | Drug and alcohol dependence | 1/4/2023 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
78 | Syqe | Online survey of medicinal cannabis users: Qualitative analysis of patient-level data | Frontiers in pharmacology | 6/9/2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
79 | Syqe | Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores | JAMA Network open | 1/6/2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
80 | Syqe | The effects of oral and vaporized cannabis alone, and in combination with alcohol, on driving performance using the STISIM driving simulator: A two-part, double-blind, double-dummy, placebo-controlled, randomized crossover clinical laboratory protocol | Frontiers in pharmacology | 6/9/2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
81 | Syqe | Smoking abstinence and cessation-related outcomes one month after an immediate versus gradual reduction in nicotine content of cigarettes | Preventive medicine | Dec 2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
82 | Syqe | Comparison of Medical Cannabis Use Reported on a Confidential Survey vs Documented in the Electronic Health Record Among Primary Care Patients | JAMA Open network | 2/5/2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
83 | Syqe | Real-Time Monitoring of Cannabis and Prescription Opioid Co-Use Patterns, Analgesic Effectiveness, and the Opioid-Sparing Effect of Cannabis in Individuals With Chronic Pain | The Journal of pain | Nov 2022 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
84 | Syqe | Antidepressant and Anxiolytic Effects of Medicinal Cannabis Use in an Observational Trial | Frontiers in psychiatry | 9/9/2021 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
85 | Syqe | Feasibility and acceptability of using smartphone-based EMA to assess patterns of prescription opioid and medical cannabis use among individuals with chronic pain | Internet interventions | 28/9/2021 | Conflict of interest | Johns Hopkins University | USA | Ryan Vandrey | ||||||||||||||
86 | Syqe | Answering Dr Lee about the future role of phenome | Journal of minimally invasive gynecology | 14/4/2024 | Conflict of interest | The Lady Davies Carmel Medical Center | Israel | Yuval Kaufman | ||||||||||||||
87 | Syqe | Is there an added value in more real-world cannabinoids studies? | European Journal of Pain | Feb. 2023 | Conflict of interest | Israel Institute of Technoology | Israel | Elon Eisenberg | ||||||||||||||
88 | Syqe | Long-term effectiveness and safety of medical cannabis administered through the metered-dose Syqe Inhaler | Pain reports | 17/5/2022 | Research cooperation | Israel Institute of Technoology | Israel | Elon Eisenberg | ||||||||||||||
89 | Syqe | Medicinal cannabis for chronic pain: The bermuda triangle of low-quality studies, countless meta-analyses and conflicting recommendations | European Journal of Pain | Jul 2022 | Conflict of interest | Israel Institute of Technoology | Israel | Elon Eisenberg | ||||||||||||||
90 | Syqe | Cannabis treatment in hospitalized patients using the SYQE inhaler: Results of a pilot open-label study | Palliative & supportive care | Feb 2020 | Conflict of interest | Israel Institute of Technoology | Israel | Elon Eisenberg | ||||||||||||||
91 | Syqe | What distinguishes patients with mass social media-induced illness presenting with Tourette-like behavior from those with Tourette syndrome? Results of a prospective cohort study | European archives of psychiatry and clinical neuroscience | Feb. 2024 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
92 | Syqe | Medicinal Use of Different Cannabis Strains: Results from a Large Prospective Survey in Germany | Pharmacopsychiatry | 12/3/2024 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
93 | Syqe | Cannabinoids in the Treatment of Selected Mental Illnesses: Practical Approach and Overview of the Literature | Pharmacopsychiatry | 1/3/2024 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
94 | Syqe | CANNA-TICS: Efficacy and safety of oral treatment with nabiximols in adults with chronic tic disorders - Results of a prospective, multicenter, randomized, double-blind, placebo controlled, phase IIIb superiority study | Psychiatry research | May 2023 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
95 | Syqe | Tourette syndrome research highlights from 2022 | F1000Research | 23/10/2023 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
96 | Syqe | Mass social media-induced illness presenting with Tourette-like behavior | Frontiers in psychiatry | 20/9/2022 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
97 | Syqe | European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment | European child & adolescent psychiatry | Mar. 2022 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
98 | Syqe | European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part I: assessment | European child & adolescent psychiatry | Mar. 2022 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
99 | Syqe | European clinical guidelines for Tourette syndrome and other tic disorders: summary statement | European child & adolescent psychiatry | Mar. 2022 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl | ||||||||||||||
100 | Syqe | European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part II: psychological interventions | European child & adolescent psychiatry | Mar. 2022 | Conflict of interest | Hannover Medical School | Germany | Kirsten Müller-Vahl |